Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease

OBJECTIVE: Serum biomarkers may serve to predict early response to therapy, identify relapse, and facilitate drug development in inflammatory bowel disease (IBD). Biomarkers are particularly important in children, in whom achieving early remission and minimizing procedures are especially beneficial....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Transl Gastroenterol
Autori principali: Heier, Christopher R, Fiorillo, Alyson A, Chaisson, Ellen, Gordish-Dressman, Heather, Hathout, Yetrib, Damsker, Jesse M, Hoffman, Eric P, Conklin, Laurie S
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2016
Soggetti:
Original Contributions
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288595/
https://ncbi.nlm.nih.gov/pubmed/27628422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ctg.2016.49
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi